MABC1117

Anti-GOLM1 Antibody, clone 6A2

clone 6A2, from mouse

• Synonym(e): Golgi membrane protein 1, Golgi membrane protein GP73, Golgi phosphoprotein 2
• UNSPSC Code: 12352203
• NACRES: NA.43
• eCl@ss: 32160702
• Conjugate: unconjugated
• Clone: 6A2, monoclonal
• Application: ELISA, IHC, IP, WB
• Citations: -

Eigenschaften

• biological source: mouse
• conjugate: unconjugated
• antibody form: purified antibody
• antibody product type: primary antibodies
• clone: 6A2, monoclonal
• species reactivity: human
• packaging: antibody small pack of 25 μg
• technique(s): ELISA: suitable, immunohistochemistry: suitable (paraffin), immunoprecipitation (IP): suitable, western blot: suitable
• isotype: IgG1κ
• NCBI accession no.: NP_808800.1
• UniProt accession no.: Q8NBJ4
• target post-translational modification: unmodified
• Gene Information: human ... GOLM1(51280)

Beschreibung

General description

45.33 kDa calculated.

Golgi membrane protein 1 (UniProt: Q8NBJ4; also known as Golgi membrane protein GP73, Golgi phosphoprotein 2) is encoded by the GOLM1 (also known as C9orf155, GOLPH2, PSEC0242, UNQ686/PRO1326) gene (Gene ID: 51280) in human. GP73 is a single-pass type II membrane protein that cycles via the cell surface and endosomes upon lumenal pH disruption. It is constitutively expressed in cells of epithelial lineage. It is highly expressed in colon, prostate, trachea, and stomach. In normal liver it is expressed at low level, but the expression is significantly increased in response to viral (HBV, HCV) infections, but not in diseases of non-viral origin. Its levels are also shown to be elevated in hepatocellular carcinoma (HCC) and in invasive breast cancer. GP73 is reported to promote HCC invasion by activation of matrix metalloproteinase-13 (MMP-13). Two isoforms of GP73 have been described that are produced by alternative initiation. (Ref.: Zhanga, A., and Caob, B. (2012). J. Biomed. Res. 26(6); 467-473; Donizy, P., et al. (2016). Int. J. Mol. Sci. 17(10); 1619.

Immunogen

His-tagged recombinant fragment corresponding to 360 amino acids from the lumenal region of human Golgi membrane protein 1.

Application

Anti-GOLM1, clone 6A2, Cat. No. MABC1117, is a mouse monoclonal antibody that detects Golgi membrane protein 1 and has been tested for use in ELISA, Immunohistochemistry (Paraffin), Immunoprecipitation, and Wrstern Blotting.

Immunohistochemistry (Paraffin) Analysis: A 1:50 dilution from a representative lot detected GOLM1 in human liver cancer tissue sections.

Enzyme Immunoassay Analysis: A representative lot detected GOLM1 in ELISA applications (Zhang, A., et. al. (2012). J Biomed Res. 26(6):467-73).

Immunohistochemistry (Paraffin) Analysis: A representative lot detected GOLM1 in Immunohistochemistry applications (Zhang, A., et. al. (2012). J Biomed Res. 26(6):467-73).

Immunoprecipitation Analysis: A representative lot immunoprecipitated GOLM1 in Immunoprecipitation applications (Zhang, A., et. al. (2012). J Biomed Res. 26(6):467-73).

Western Blotting Analysis: A representative lot detected GOLM1 in Western Blotting applications (Zhang, A., et. al. (2012). J Biomed Res. 26(6):467-73).

Research Category
Apoptosis & Cancer

Biochem/physiol Actions

Clone 6A2 specifically detects human Golgi membrane protein 1. It targets an epitope with in the lumenal domain.

Physical form

Format: Purified

Protein G purified

Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.

Analysis Note

Evaluated by Immunohistochemistry (Paraffin) in human prostate cancer tissue sections.

Immunohistochemistry (Paraffin) Analysis: A 1:250 dilution of this antibody detected GOLM1 in human prostate cancer tissue sections.

Other Notes

Concentration: Please refer to lot specific datasheet.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.